NRG Oncology PREDICT-RT Study Completes Enrollment, Evaluates Tailored Concurrent Therapy and Radiation for High-Risk Prostate Cancer
PHILADELPHIA, PA – In a striking advancement for personalized cancer treatment, the NRG Oncology-led NRG-GU009 (PREDICT-RT) trial, which explores the ...
